Groowe Groowe / Newsroom / PFE
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PFE News

Pfizer Inc.

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

businesswire.com
PFE

Top 10 Great Reasons to Visit Velocity Invitational at Sonoma Raceway This Weekend!

globenewswire.com
TSLA GM RACE PAG HOG F VWAGY RIVN LCID NIO XPEV WKHS HYMC CHPT EVGO BLNK PSNY PGR GE GOOG META AMZN MSFT NVDA AMD INTC QCOM MU AMAT ASML LRCX KLAC TER ADI NXPI ON MCHP AEHR ENPH SEDG PLUG FCEL BE BALL CPRT CAR AZZ ALGN BIIB REGN GILD AMGN BMY MRK PFE JNJ ABBV AZN SNOW DDOG CRWD PANW FTNT OKTA SMCI CRIS EDIT BEAM NTLA BNTX MRNA COIN PYPL MP PLTR AI UPST SOFI HOOD ETSY MELI BABA JD NFLX DIS CMCSA EA TTWO RBLX

AI Supercomputing Platform Market Research 2026-2032: Competition Intensifies as NVIDIA Leads While AMD, Intel and Hyperscalers Expand Custom Silicon Strategies

globenewswire.com
NVDA AMD INTC HPE DELL MSFT AMZN GOOG ORCL SMCI MU META TSM BRO CSCO IBM ARM AMAT LRCX KLAC QCOM CRSP REGN GILD BMY MRNA BIIB EXAS ILMN VRTX AZN PFE JNJ AMGN LLY ABBV BKR XOM CVX NEE DUK SO ED PCG SRE AEP WEC ETR NI XEL NRG CEG EIX FE D CMS PNW ES

ixlayer Appoints Helmut Osorio as General Manager to Accelerate Direct-to-Patient Growth for Biopharma

prnewswire.com
REGN PFE

$94 Bn Vaccines Market Industry Trends and Global Forecasts, 2026-2035: 200+ Preventive Vaccines, Developed by Both Industry and Non-industry Players are Being Evaluated

globenewswire.com
EBS NVAX MRNA PFE

CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research

prnewswire.com
AMGN LLY TEVA PFE ABBV

Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

globenewswire.com
SNGX IPHA BMY NKTX AZN MRK TAK NVS GMAB ABBV BIIB CRSP INCY ALKS PFE REGN GILD AMGN

Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson

globenewswire.com
AMGN FMS DVA ABBV NVS MRK PFE SNY JNJ

Polycystic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Otsuka Pharmaceutical, Novartis, Pfizer, and Vertex Pharmaceuticals

globenewswire.com
NVS PFE VRTX

Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals

globenewswire.com
BDX MRK PFE